# Renal Denervation in Diabetic Nephropathy

> **NCT01588795** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 25 (actual)

## Conditions studied

- Diabetic Nephropathy
- Persistent Proteinuria With Type II Diabetes

## Interventions

- **PROCEDURE:** Percutaneous renal denervation and TMNS
- **DRUG:** Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin

## Key facts

- **NCT ID:** NCT01588795
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588795, "Renal Denervation in Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01588795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*